Artivion (AORT) SVP exercises options and sells 44,001 shares under 10b5-1 plan

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

ARTIVION, INC. senior vice president Andrew M. Green reported an exercise-and-sell transaction in company stock. He exercised stock options for a total of 44,001 shares of common stock at exercise prices of $11.03 and $18.44 per share, then sold the same 44,001 shares in open-market transactions at weighted average prices of $20.694 and $20.707 per share. These trades were carried out on June 11, 2026 under a pre-arranged Rule 10b5-1 trading plan. Following the transactions, Green continued to hold 60,259 shares of Artivion common stock directly.

Insider Trade Summary 10b5-1

Net Seller: 44,001 shares ($910,739)

Net Sell 6 txns

Insider GREEN ANDREW M

Role SVP, Regulatory and Quality

Sold 44,001 shs ($911K)

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to buy)	14,001	$0.00	--
Exercise	Stock Options (Right to buy)	30,000	$0.00	--
Exercise	Common Stock	14,001	$18.44	$258K
Sale	Common Stock	14,001	$20.707	$290K
Exercise	Common Stock	30,000	$11.03	$331K
Sale	Common Stock	30,000	$20.694	$621K

Holdings After Transaction: Stock Options (Right to buy) — 0 shares (Direct, null); Common Stock — 74,260 shares (Direct, null)

Footnotes (1)

The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026. Reflects weighted average price. Range of prices were between $20.25 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects weighted average price. Range of prices were between $20.24 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023. Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

Key Figures

Shares sold (total): 44,001 shares First sale tranche: 30,000 shares at $20.694 Second sale tranche: 14,001 shares at $20.707 +3 more

6 metrics

Shares sold (total) 44,001 shares Common stock sold in open market on June 11, 2026

First sale tranche 30,000 shares at $20.694 Weighted average sale price for part of the transaction

Second sale tranche 14,001 shares at $20.707 Weighted average sale price for remaining shares

Options exercised (total) 44,001 shares Common shares acquired via option exercises on June 11, 2026

Option strike prices $11.03 and $18.44 Exercise prices for 30,000 and 14,001 share option grants

Shares held after 60,259 shares Direct Artivion common stock ownership following transactions

Key Terms

Rule 10b5-1 trading plan, weighted average price, Stock options (Right to buy), Exercise or conversion of derivative security, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"Reflects weighted average price. Range of prices were between $20.25 to $21.02."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Stock options (Right to buy) financial

"Stock options (Right to buy) ... underlying security title: Common Stock"

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/15/2026 - 11:28 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GREEN ANDREW M

(Last)

(First)

(Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW

GEORGIA

30144

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Regulatory and Quality

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/11/2026		M		14,001⁽¹⁾	A	$18.44	74,260	D
Common Stock	06/11/2026		S		14,001⁽¹⁾	D	$20.707⁽²⁾	60,259	D
Common Stock	06/11/2026		M		30,000⁽¹⁾	A	$11.03	90,259	D
Common Stock	06/11/2026		S		30,000⁽¹⁾	D	$20.694⁽³⁾	60,259	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (Right to buy)	$18.44	06/11/2026		M			14,001⁽¹⁾	02/23/2023⁽⁴⁾	02/23/2029	Common Stock	14,001	$0	0	D
Stock Options (Right to buy)	$11.03	06/11/2026		M			30,000⁽¹⁾	11/08/2023⁽⁵⁾	11/08/2029	Common Stock	30,000	$0	0	D

Explanation of Responses:

1. The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

2. Reflects weighted average price. Range of prices were between $20.25 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. Reflects weighted average price. Range of prices were between $20.24 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023.

5. Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

Remarks:

	/s/ Andrew M. Green	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did ARTIVION (AORT) report for Andrew M. Green?

ARTIVION reported that SVP Andrew M. Green exercised stock options for 44,001 shares and sold the same 44,001 shares in open-market transactions, while maintaining direct ownership of 60,259 common shares after the trades.

How many ARTIVION (AORT) shares did Andrew M. Green sell and at what prices?

Andrew M. Green sold 44,001 ARTIVION common shares in total. He sold 30,000 shares at a weighted average price of about $20.694 and 14,001 shares at a weighted average price of about $20.707 per share.

What stock options did Andrew M. Green exercise in this ARTIVION (AORT) Form 4?

He exercised options covering 30,000 shares at an exercise price of $11.03 and 14,001 shares at an exercise price of $18.44, converting these derivative positions into common stock before selling the resulting shares.

How many ARTIVION (AORT) shares does Andrew M. Green own after the transactions?

After exercising options and selling the resulting shares, Andrew M. Green directly holds 60,259 shares of ARTIVION common stock. The filing shows no remaining derivative option position associated with these exercised grants.

Were Andrew M. Green’s ARTIVION (AORT) stock sales under a Rule 10b5-1 plan?

Yes. The Form 4 footnotes state that the option exercises and subsequent sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Andrew M. Green on March 12, 2026, indicating a pre-arranged transaction schedule.

What price ranges applied to Andrew M. Green’s ARTIVION (AORT) stock sales?

The filing reports weighted average prices, noting ranges. One sale tranche occurred between $20.25 and $21.02, and the other between $20.24 and $21.02. Detailed per-trade prices are available from the reporting person upon request.